ViewRay Inc (VRAY)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Chris A. Raanes
Employees:
221
2 THERMO FISHER WAY, OAKWOOD VILLAGE, OH 44146
440-703-3210

ViewRay, Inc. engages in the research, development, and manufacture of magnetic resonance imaging (""MRI"") system. Its product, MRIdian, supports image-guided radiation therapy, stereotactic radiation therapy, and radiosurgery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Data derived from most recent annual or quarterly report
Market Cap 668.851 Million Shares Outstanding164.742 Million Avg 30-day Volume 1.32 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.36
Price to Revenue12.0698 Debt to Equity0.3468 EBITDA-96.495 Million
Price to Book Value4.2795 Operating Margin-172.5743 Enterprise Value578.573 Million
Current Ratio5.134 EPS Growth0.311 Quick Ratio4.037
1 Yr BETA 1.6882 52-week High/Low 8.25 / 3.79 Profit Margin-183.7628
Operating Cash Flow Growth39.7424 Altman Z-Score0.0984 Free Cash Flow to Firm -50.823 Million
View SEC Filings from VRAY instead.

View recent insider trading info

Funds Holding VRAY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRAY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILENSKY GAIL R

  • Director
143,155 2022-01-03 2

JOHNSON B KRISTINE

  • Director
194,533 2022-01-03 2

CASTELEIN CALEY

  • Director
958,977 2022-01-03 3

MOORE DANIEL JEFFREY

  • Director
176,640 2022-01-03 2

SPENCER PHILLIP M

  • Director
87,791 2022-01-03 5

XIE YILI KEVIN

  • Director
177,315 2022-01-03 2

FOSUN INTERNATIONAL LTD

  • SEE REMARKS
0 2021-11-19 3

DRAKE SCOTT WILLIAM PRESIDENT & CEO

  • Officer
  • Director
3,716,281 2021-11-19 5

STASSEN ZACHARY WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
465,290 2021-11-19 4

STRONG INFLUENCE LTD

  • 10% Owner
11,108,222 2021-11-08 2

MCCORMACK ROBERT S SVP GEN COUNSEL & CORP SEC

  • Officer
479,634 2021-10-24 2

ZIEGLER PAUL JR CHIEF COMMERCIAL OFFICER

  • Officer
294,826 2021-10-24 3

PRANGE KAREN

  • Director
46,154 2021-07-01 3

ROBERTS BRIAN K

  • Director
131,761 2021-06-14 1

MATIN SHAHRIAR CHIEF OPERATING OFFICER

  • Officer
1,589,687 2021-03-01 1

DEMPSEY JAMES F. CHIEF SCIENTIFIC OFFICER

  • Officer
1,484,249 2021-03-01 1

GROSSMAN D KEITH

  • Director
100,855 2021-01-04 0

HUENNEKENS R SCOTT

  • Director
99,670 2020-06-15 0

KNALEY BRIAN SR VP AND INTERIM CFO

  • Officer
242,919 2020-03-02 0

ALECXIH JAMES CHIEF COMMERCIAL OFFICER

  • Officer
278,371 2019-10-24 0

BANSAL AJAY CHIEF FINANCIAL OFFICER

  • Officer
98,876 2019-07-25 0

MCKINNELL HENRY A

  • Director
689,046 2019-01-02 0

PURI ADITYA

  • Director
4,938,298 2019-01-02 0

WANG THEODORE T

  • Director
34,117 2019-01-02 0

MCKINNELL HENRY A

MCKINNELL HENRY A

  • Director
0 2018-12-21 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

  • 10% Owner
14,915,535 2018-08-16 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2018-08-08 0

RAANES CHRIS PRESIDENT AND CEO

  • Officer
  • Director
0 2018-05-15 0

KEARE DOUGLAS CHIEF OPERATING OFFICER

  • Officer
0 2018-04-16 0

GOLD MARK STEPHEN

  • Director
319,174 2017-11-15 0

BONITA DAVID P

  • Director
  • 10% Owner
9,484,955 2017-11-15 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • Director
  • 10% Owner
9,462,410 2017-01-18 0

PUISSANCE CROSS-BORDER OPPORTUNITIES I LP

PUISSANCE CAPITAL FUND (GP) LLC

PUISSANCE CAPITAL MANAGEMENT LP

PUISSANCE CAPITAL MANAGEMENT (GP) LLC

WANG THEODORE T

  • 10% Owner
6,842,975 2017-01-18 0

BILENKER JOSHUA H.

  • Director
  • 10% Owner
7,480,887 2016-09-13 0

AISLING CAPITAL II LP

AISLING CAPITAL PARTNERS LLC

AISLING CAPITAL PARTNERS, LP

SCHIFF ANDREW N

PURCELL DENNIS J

ELMS STEVE

  • 10% Owner
7,461,923 2016-03-30 0

CHANDLER D. DAVID CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-30 0

BRANDT MICHAEL SENIOR VICE PRESIDENT OF SALES

  • Officer
0 2016-03-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CASTELEIN CALEY - Director

2022-01-05 17:07:20 -0500 2022-01-03 A 12,521 $5.83 a 828,377 direct -5.8 -3.2 0.2 5 -5.8 2

SPENCER PHILLIP M - Director

2022-01-05 17:08:17 -0500 2022-01-03 A 9,605 $5.83 a 87,791 direct -5.8 -3.2 0.2 5 -5.8 2

MOORE DANIEL JEFFREY - Director

2022-01-05 17:07:51 -0500 2022-01-03 A 19,897 $5.83 a 176,640 direct -5.8 -3.2 0.2 5 -5.8 2

JOHNSON B KRISTINE - Director

2022-01-05 17:08:40 -0500 2022-01-03 A 10,806 $5.83 a 182,533 direct -5.8 -3.2 0.2 5 -5.8 2

XIE YILI KEVIN - Director

2022-01-05 17:09:48 -0500 2022-01-03 A 8,233 $5.83 a 177,315 direct -5.8 -3.2 0.2 5 -5.8 2

WILENSKY GAIL R - Director

2022-01-05 17:09:14 -0500 2022-01-03 A 9,605 $5.83 a 143,155 direct -5.8 -3.2 0.2 5 -5.8 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VIEWRAY INC VRAY 2022-01-28 19:15:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 18:45:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 18:15:04 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 17:45:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 17:15:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 16:45:04 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 16:15:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 15:45:04 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 15:15:03 UTC -0.4295 0.4995 1500000
VIEWRAY INC VRAY 2022-01-28 14:45:03 UTC -0.4993 0.5693 1500000
VIEWRAY INC VRAY 2022-01-28 14:15:03 UTC -0.4993 0.5693 1500000
VIEWRAY INC VRAY 2022-01-28 13:45:03 UTC -0.4993 0.5693 1500000
VIEWRAY INC VRAY 2022-01-28 13:15:03 UTC -0.4993 0.5693 1500000
VIEWRAY INC VRAY 2022-01-28 12:45:03 UTC -0.4993 0.5693 1500000
VIEWRAY INC VRAY 2022-01-27 22:15:03 UTC -0.4993 0.5693 1600000
VIEWRAY INC VRAY 2022-01-27 21:45:03 UTC -0.4993 0.5693 1600000
VIEWRAY INC VRAY 2022-01-27 21:15:03 UTC -0.4993 0.5693 1600000
VIEWRAY INC VRAY 2022-01-27 20:45:03 UTC -0.4993 0.5693 1600000
VIEWRAY INC VRAY 2022-01-27 20:15:04 UTC -0.4993 0.5693 1600000
VIEWRAY INC VRAY 2022-01-27 19:45:03 UTC -0.4993 0.5693 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund VRAY -903.0 shares, $-2618.7 2019-09-30 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VRAY -4955.0 shares, $-35725.55 2021-09-30 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND VRAY -52344.0 shares, $-377400.24 2021-09-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VRAY -31424.0 shares, $-229709.44 2021-10-31 N-PORT
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund VRAY -131633.0 shares, $-962237.23 2021-10-31 N-PORT

Elevate your investments